Horizon Pharmaceutical LLC

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson -0.11%148.370.7%$877.32m
BMYBristol-Myers Squibb Co. -4.05%64.161.0%$804.09m
PFEPfizer Inc. -2.16%39.830.9%$667.18m
MRKMerck & Co., Inc. -2.93%85.970.7%$647.43m
ABBVAbbVie, Inc. -2.01%83.562.3%$617.98m
LLYEli Lilly & Co. -1.55%139.021.1%$425.04m
NVSNovartis AG -1.11%93.870.2%$145.91m
GSKGlaxoSmithKline Plc -1.22%47.240.2%$112.00m
APLSApellis Pharmaceuticals, Inc. -2.34%41.300.0%$110.32m
AZNAstraZeneca Plc -1.83%49.281.2%$101.75m
KRTXKaruna Therapeutics, Inc. 0.00%99.750.0%$73.45m
NVONovo Nordisk A/S -0.81%61.090.1%$72.43m
SNYSanofi -1.75%48.730.2%$63.37m
RETAReata Pharmaceuticals, Inc. -6.45%193.493.5%$59.40m
ENDPEndo International Plc -10.24%5.928.8%$43.86m

Company Profile

Horizon Pharmaceutical LLC develops transformative treatments for people affected by rare and debilitating diseases. It offers PROCYSBI, a delayed-release capsule, which is used for the management of nephropathic cystinosis in adults and for six years and older children. The company was founded by Christopher M. Starr and Todd C. Zankel in 2006 and is headquartered in Novato, CA.